ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 649

Altered BMP Signalling In a TGFβ Dependent Murine Model Of Scleroderma May Contribute To Development Of Pulmonary Arterial Hypertension

Adrian J Gilbane1, Emma C. Derrett-Smith2, Sarah Trinder3, Andrew Pearce4, Christopher P. Denton1 and Alan M. Holmes5, 1Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, 2Centre for Rheumatology and Connective Tissue Diseases,, UCL Medical School Royal Free Campus, London, United Kingdom, 3Centre for Rheumatology and Connective Tissue Disease, UCL Medical School, London, United Kingdom, 4Respiratory Disease Area, Novartis, London, United Kingdom, 5Centre for Rheumatology and Connective Tissue Diseases, UCL, London, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Animal models and scleroderma

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Pulmonary arterial hypertension associated is an important complication of scleroderma (PAH-SSc) and has a poor prognosis compared to idiopathic (iPAH) or heritable (hPAH) forms of the disease. BMPRII mutations with concomitant effects on BMP signalling are an established cause of hPAH and some iPAH but these are not present in PAH-SSc. Furthermore, alterations in signalling through other TGFβ superfamily pathways have reciprocal effects on the BMP pathway.

Methods:

We investigated BMP signalling in the lung in a mouse model of SSc in which TGFβ signalling is upregulated. Experiments were performed on whole lung isolates and explant cultured fibroblasts (n=6) from the TβRIIΔk-fib mouse and compared with wild type (WT) controls. Structural and biochemical analysis of components of the TGFβ superfamily and downstream signalling pathway was investigated by Western blot, immunohistochemistry and confirmed using qPCR measurement. Migration assays investigated the effects of PDGF-BB on lung fibroblasts from TβRIIΔk-fib and WT controls (n=3). Confirmatory biochemical and functional studies on scleroderma fibroblasts were also performed.

Results:

The TβRIIΔk-fib model has increased levels of pSmad 2/3, indicative of enhanced TGFβ signalling. Consistent with an imbalance in the TGFβ/BMP axis we observed a significant reduction in BMPRII protein expression in the TβRIIΔk-fib model, both in whole lung isolates (1.43, 0.38) (p<0.05), and explant cultured fibroblasts (0.2985, 0.09) (p<0.05) (figure1). Explant cultured fibroblasts exhibited a blunted induction of phospho-Smad1 in response to BMP ligands (p<0.05) (figure1). TβRIIΔk-fib lung fibroblasts also exhibited enhanced migratory response compared to wild type controls (p<0.05). These findings were confirmed in scleroderma fibroblast studies, highlighting a reduction in BMPRII levels and an increased migratory response compared to healthy controls (p<0.05).

Conclusion:

Association of altered BMPRII expression with PAH is well established in hPAH. Here we demonstrate the TβRIIΔk-fib model of SSc that develops a constitutive pulmonary vasculopathy, exhibits reduced expression of BMPRII as a reciprocal response to increased TGFβ signalling, with associated downstream signalling alterations independent of mutations in the BMPRII. Collectively our data suggests loss of BMPRII expression by non-genetic means may contribute to the development of PH in the TβRIIΔk-fib model of SSc.


Disclosure:

A. J. Gilbane,
None;

E. C. Derrett-Smith,
None;

S. Trinder,
None;

A. Pearce,
None;

C. P. Denton,
None;

A. M. Holmes,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/altered-bmp-signalling-in-a-tgf%ce%b2-dependent-murine-model-of-scleroderma-may-contribute-to-development-of-pulmonary-arterial-hypertension/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology